nomela®

Melanoma risk-assessment technology

Non-invasive screening aid to indicate the chance of melanoma in pigmented skin lesions (moles)

On-device AI by machine-learning
Single-application iPads
For use by medical professionals

Applies automated edge detection to exclude surrounding skin

Cyber Security Plus certified
QMS ISO 13485 certified

The nomela® test

Contact us

Contact